Goldman Sachs
DICE

Goldman Sachs’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Goldman Sachs’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,000
Closed -$465K – 6039
2023
Q2 		$465K Buy
+10,000
New +$346K ﹤0.01% 4788

Goldman Sachs's DICE Position: Q3 2023 in Review

Goldman Sachs sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 707,039 shares — an estimated $32.8M sold.

Goldman Sachs first reported a position in DICE in Q3 2021 and held it in 7 quarters. The position peaked at $32.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Goldman Sachs reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Goldman Sachs sold 707,039 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $32.8M.
  • Goldman Sachs first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • Goldman Sachs's DICE Therapeutics, Inc. Common Stock position peaked at $32.8M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.